Mission

Our goal is to translate world-class academic research into small molecule drug development candidates for clinical trials

COLLABORATIVE RESEARCH

  • QEDDI is about drug discovery and collaboration. We aim to translate innovative academic research towards clinical development for the treatment of cancer, metabolic and inflammatory disorders, neurodegenerative and infectious diseases.
  • Academia is rich in drug target biology – targets that are generally too early to commercialise. QEDDI will collaborate with researchers, by providing high quality and efficient drug discovery support and industry-based project management to advance academic research into small molecule drug candidates. 

ENABLING COMMERCIAL PARTNERSHIPS

  • QEDDI will bridge the gap (the 'Valley of Death') between academic research groups with potentially valuable therapeutic concepts, and pharma or biotech companies seeking novel strategies for clinical development. 
  • QEDDI will develop and de-risk biomedical research to a stage ready for partnering with industry, enabling further development of the technology.
QEDDI Diagram

BENEFITS FOR ALL PARTIES

  • For researchers: QEDDI will compliment and add value to the rich knowledge base of disease pathways and target biology.
  • For government: QEDDI will foster an innovative ecosystem for Queensland drug discovery research and attract and retain a highly-skilled workforce.
  • For industry: QEDDI will provide a pipeline of drug leads and candidates based on novel and differentiated therapeutic concepts.

PARTNERS

QEDDI acknowledges the following organisations for their support and advice: